Amanote Research
Register
Sign In
A miRNA Signature Assessing Ovarian Cancer Prognosis
Oncoscience
- United States
doi 10.18632/oncoscience.329
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 2, 2016
Authors
Unknown
Publisher
Impact Journals, LLC
Related search
A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
PLoS ONE
Multidisciplinary
A Plasma miRNA Signature for Lung Cancer Early Detection
Oncotarget
Oncology
Common Analgesics and Ovarian Cancer Prognosis
The Lancet Oncology
Oncology
Retraction Note: Risk miRNA Screening of Ovarian Cancer Based on miRNA Functional Synergistic Network
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
[Corrigendum] a 19‑miRNA Support Vector Machine Classifier and a 6‑miRNA�risk Score System Designed for Ovarian Cancer Patients
Oncology Reports
Medicine
Cancer Research
Oncology
Overexpression of miRNA-221 Promotes Cell Proliferation by Targeting the Apoptotic Protease Activating Factor-1 and Indicates a Poor Prognosis in Ovarian Cancer
International Journal of Oncology
Cancer Research
Oncology
Population Analysis of Microsatellite Genotypes Reveals a Signature Associated With Ovarian Cancer
Oncotarget
Oncology
A Panel of 13-miRNA Signature as a Potential Biomarker for Predicting Survival in Pancreatic Cancer
Oncotarget
Oncology
Development of a 15-Gene Signature for Predicting Prognosis in Advanced Colorectal Cancer
Bioengineered
Applied Microbiology
Biotechnology
Medicine
Bioengineering
